Search alternatives:
significantly elevated » significantly greater (Expand Search), significantly correlated (Expand Search), significantly decreased (Expand Search)
elevated decrease » elevated depressive (Expand Search), estimated decrease (Expand Search), greater decrease (Expand Search)
significantly elevated » significantly greater (Expand Search), significantly correlated (Expand Search), significantly decreased (Expand Search)
elevated decrease » elevated depressive (Expand Search), estimated decrease (Expand Search), greater decrease (Expand Search)
-
1
-
2
-
3
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
Published 2025“…<p><b>(A)</b> A significant decrease in the proliferative clonal capacity of U87MG colonies was observed with 70ΜM and 100ΜM SHG-44 treatment. …”
-
4
-
5
Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations.
Published 2025“…<p><b>(A)</b> A significant reduction in colony-forming ability was observed in U87MG cells treated with 100ΜM SHG-44 compared to 100ΜM cis-platin and the untreated control. …”
-
6
-
7
-
8
CCR2 deficiency elevates <i>C</i>. <i>muridarum</i>-induced Th17-type immune response.
Published 2025Subjects: -
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.
Published 2025“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”
-
20